{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-158944","form_type":"8-K","ticker":"AKTS","cik":"0002035832","company_name":"Aktis Oncology, Inc.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.425818+00:00","generated_at":"2026-05-15T05:56:09.605392+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Aktis Oncology appoints Glenn Gormley to board; two directors resign","bullets":["Glenn Gormley, MD, PhD appointed independent director and co-chair of new Science and Technology Committee, effective April 15, 2026.","Gormley, 72, previously Global Head of R&D at Daiichi Sankyo; over 30 years biopharma leadership.","Received option for 37,866 shares vesting over three years; annual cash compensation $45,000 plus $15,000 for committee role.","Helen S. Kim and Oleg Nodelman resign from board effective May 20, 2026; not due to any disagreement.","Gormley joins as company advances clinical milestones in targeted radiopharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-158944","json":"https://secwatch.observer/filing/0001193125-26-158944.json","markdown":"https://secwatch.observer/filing/0001193125-26-158944.md","text":"https://secwatch.observer/filing/0001193125-26-158944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526158944/0001193125-26-158944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2035832/000119312526158944/d110479d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:56:09.605392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}